financetom
Business
financetom
/
Business
/
Oil demand to fall to 80-100 million bpd by 2035, says BP's US chief economist
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil demand to fall to 80-100 million bpd by 2035, says BP's US chief economist
Nov 15, 2024 11:09 AM

HOUSTON, Nov 13 (Reuters) - Global oil demand will fall

to around 80 million barrels per day by 2035 in a net-zero

environment, and 100 million bpd in the current trajectory

scenario, BP's chief U.S. economist told an energy

conference in Dallas on Wednesday.

Crude oil demand is about 102 million bpd now, and the

forecast assumes renewables and more efficient motor vehicles

increase over that period. But BP's Michael Cohen said the world

will need continued investment in fossil fuels to ensure an

orderly transition to cleaner energy.

Non-OPEC oil supply growth will exceed demand growth over

the next several years, limiting the ability of the Organization

of the Petroleum Exporting Countries to add more barrels to the

global market, Cohen said.

Market changes also will produce a shift in output and

configurations at oil refineries. Refiners will shift their

plants to produce more naphtha to replace gasoline, and there

will be greater integration of oil and petrochemical operations,

Cohen said.

The portion of gasoline compared with other refined products

supplied by refiners will drop to about 15% by 2050, from 25%

today, he said. Automakers will continue to build internal

combustible engine vehicles, and there will be more miles driven

worldwide, Cohen said, but light vehicles will be more

fuel-efficient.

The drop in gasoline demand will particularly affect

European refineries, Cohen said.

"The Atlantic Basin component of refining throughput

declines is the largest of any of the different regions," said

Cohen.

While investment in oil and gas production will remain

stable, there will be a massive increase in spending on

renewable energy, he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved